Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

Science

Volumn 349, Issue 6245, 2015, Pages 320-324

  Barouch, Dan H ^a,b   Alter, Galit ^b   Broge, Thomas ^b   Linde, Caitlyn ^b   Ackerman, Margaret E ^c   Brown, Eric P ^c   Borducchi, Erica N ^a   Smith, Kaitlin M ^a   Nkolola, Joseph P ^a   Liu, Jinyan ^a   Shields, Jennifer ^a   Parenteau, Lily ^a   Whitney, James B ^a   Abbink, Peter ^a   Ng'ang'a, David M ^a   Seaman, Michael S ^a   Lavine, Christy L ^a   Perry, James R ^a   Li, Wenjun ^d   Colantonio, Arnaud D ^a   Lewis, Mark G ^e   Chen, Bing ^f   Wenschuh, Holger ^g   Reimer, Ulf ^g   Piatak, Michael ^l   Lifson, Jeffrey D ^h   Handley, Scott A ⁱ   Virgin, Herbert W ⁱ   Koutsoukos, Marguerite ^j   Lorin, Clarisse ^j   Voss, Gerald ^j   Weijtens, Mo ^k   Pau, Maria G ^k   Schuitemaker, Hanneke ^k   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c DARTMOUTH COLLEGE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e BIOQUAL INC   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g JPT Peptide Technologies GmbH   (Germany)

^h FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j GSK   (Belgium)

^k Janssen Research and Development   (Netherlands)

^l Janssen Infectious Diseases and Vaccines ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VACCINE; ENVELOPE PROTEIN; GLYCOPROTEIN GP 140; GAG PROTEIN; HLA ANTIGEN CLASS 1; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; POL PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ENVELOPE PROTEIN;

ANTIBODY; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS; NEUTRALIZATION; PRIMATE; PROTEIN; VACCINE; VIRUS;

ADENOVIRIDAE; ADENOVIRUS SEROTYPE 26; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG EFFICACY; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS NEUTRALIZATION; ADOPTIVE TRANSFER; ANIMAL; FEMALE; GENE VECTOR; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MALE; SECONDARY IMMUNIZATION;

ADENOVIRIDAE; ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

ADENOVIRUS VACCINES; ADOPTIVE TRANSFER; AIDS VACCINES; ANIMALS; ANTIBODIES, NEUTRALIZING; FEMALE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; IMMUNIZATION, SECONDARY; MACACA MULATTA; MALE; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84937950533     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aab3886     Document Type: Article

References (37)

1. A. S. Fauci, H. D. Marston, N. Engl. J. Med. 370, 495-498 (2014).
2. D. H. Barouch, N. Engl. J. Med. 369, 2073-2076 (2013).
3. N. L. Letvin et al., Sci. Transl. Med. 3, 81ra36 (2011).
4. S. M. Hammer et al., N. Engl. J. Med. 369, 2083-2092 (2013).
5. D. H. Barouch et al., Nature 482, 89-93 (2012).
6. D. H. Barouch et al., Cell 155, 531-539 (2013).
7. P. Abbink et al., J. Virol. 81, 4654-4663 (2007).
8. B. Chen et al., J. Biol. Chem. 275, 34946-34953 (2000).
9. R. Vogels et al., J. Virol. 77, 8263-8271 (2003).
10. J. P. Nkolola et al., J. Virol. 84, 3270-3279 (2010).
11. D. Montefiori, Curr. Protoc. Immunol. Chap. 12 (Unit 12.11), 1-15 (2005).
12. A. W. Chung, G. Alter, Future Virol 9, 397-414 (2014).
13. M. E. Ackerman, G. Alter, Curr. HIV Res. 11, 365-377 (2013).
14. M. E. Ackerman et al., J. Immunol. Methods 366, 8-19 (2011).
15. V. R. Gómez-Román et al., J. Immunol. Methods 308, 53-67 (2006).
16. A. W. Chung et al., Sci. Transl. Med. 6, 228ra38 (2014).
17. E. P. Brown et al., J. Immunol. Methods 386, 117-123 (2012).
18. A. W. Boesch et al., MAbs 6, 915-927 (2014).
19. K. S. Lau et al., Sci. Signal. 4, ra16 (2011).
20. L. J. Picker et al., J. Clin. Invest. 116, 1514-1524 (2006).
21. H. Li et al., J. Virol. 85, 11007-11015 (2011).
22. J. Liu et al., Nature 457, 87-91 (2009).
23. J. Liu et al., J. Virol. 84, 10406-10412 (2010).
24. S. A. Handley et al., Cell 151, 253-266 (2012).
25. E. Aronesty, in code.google.com/p/ea-utils. (ea-utils, Durham, NC, 2011).
26. L. Fu, B. Niu, Z. Zhu, S. Wu, W. Li, Bioinformatics 28, 3150-3152 (2012).
27. D. H. Huson, S. Mitra, H.-J. Ruscheweyh, N. Weber, S. C. Schuster, Genome Res. 21, 1552-1560 (2011).
28. S. G. Hansen et al., Nature 502, 100-104 (2013).
29. D. H. Barouch et al., Nat. Med. 16, 319-323 (2010).
30. J. M. Kovacs et al., Proc. Natl. Acad. Sci. U.S.A. 109, 12111-12116 (2012).
31. A. Masch, J. Zerweck, U. Reimer, H. Wenschuh, M. Schutkowski, Methods Mol. Biol. 669, 161-172 (2010).
32. K. E. Stephenson et al., J. Immunol. Methods 416, 105-123 (2015).
33. S. Rerks-Ngarm et al., N. Engl. J. Med. 361, 2209-2220 (2009).
34. B. F. Haynes et al., N. Engl. J. Med. 366, 1275-1286 (2012).
35. M. Roederer et al., Nature 505, 502-508 (2014).
36. S. W. Barnett et al., J. Virol. 84, 5975-5985 (2010).
37. S. G. Hansen et al., Nature 473, 523-527 (2011).